RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Apoptosi e terapia del cancro: caratterizzazione di nuovi meccanismi e nuove molecole modulatrici dell'apoptosi
• 2 - Ruolo delle cellule staminali prostatiche e della stimolazione ipossica nella progressione tumorale.
• 3 - Estrogeni, recettori steroidei e carcinoma prostatico: modulazione dei meccanismi biomolecolari coinvolti nella progressione e metastatizzazione del tumore
• 4 - Meccanismi molecolari di carcinogenesi: validazione di nuovi bersagli per la diagnosi e la terapia
• 5 - CONTROLLO DEL CICLO CELLULARE DA LIGANDI DI RECETTORI NUCLEARI
• 6 - Vie di trasduzione e modifiche traduzionali e post-traduzionali nella protezione dall'apoptosi: disegno di nuove strategie terapeutiche antitumorali.
• 7 - ANALISI DEI MECCANISMI DI SOPRAVVIVENZA CELLULARE DI EUCARIOTI MEDIANTE STRATEGIE DI PROTEOMICA
• 8 - Basi molecolari della tumorigenesi neuronale indotta da alterazioni dello sviluppo cellulare: ruolo di Hedgehog e pathways interattive.
• 9 - MECCANISMI REDOX DI SEGNALAZIONE CELLULARE COINVOLTI NELLA GENESI DI MALATTIE ASSOCIATE A STRESS OSSIDATIVO
• 10 - Ruolo dell'angiogenesi e dell'infiammazione nella progressione tumorale

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • ONCOLOGIA MEDICA
  • ANATOMIA PATOLOGICA
  • NEUROCHIRURGIA
  • PEDIATRIA GENERALE E SPECIALISTICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Lazio

Bibliografia

1.Gilbertson RJ: Medulloblastoma: signalling a change in treatment. The Lancet Oncoloy 2005; 5: 209-218
2.Gajjar A et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004 22(6):984-93
3.Ruiz i Altaba A et. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002 2:361-72.
4.Giangaspero F et al.. Pathology & Genetics. Tumours of the nervous system. , IARC Press, Lyon. 2000
5.Ellison D. Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol. 2002 28(4):25715.
6.Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol Med, 11, 17-22, 2005
7.Zurawel, R. H.,. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes.Cancer 2000; 27, 44-51
8.Taylor MD al. Mutations in SUFU predispose to medulloblastoma Nat Genet 2002, 31 :306-10
9.Eberhart CG. Medulloblastoma in mice lacking p53 and PARP. All roads lead to Gli. Am J Pathol, 2003;162, 7-9
10.Eberhart CG et al. Nuclear localization and mutation of β-Catenin in medulloblastomas. J Neuropathol Exp Neurol, 59, 333-337, 2000
11.Ellison DW et al.beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the united kingdom children’s cancer study group brain tumor committee. J Clin Oncol, 23, 7951-7957, 2005
12.Dahmen RP et al.Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61, 7039-7043, 2001
13.van Noort M et al.WNT signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277, 17901-17905, 2002
14.van Es JH et al. You WNT some, you lose some: oncogenes in the WNT signaling pathway. Curr Opin Genet Dev 13, 28-33, 2003
15.Sekiya T et al. Overexpression of Icat induces G2 arrest and cell death in tumor cell mutants for Adenomatous Polyposis Coli, β-catenin, or Axin. Cancer Res, 62, 3322-3326, 2002
16.Valizadeh A et al. Expression of E cadherin-associated molecules in colorectal polyps. Am J Pathol, 150, 1977-1984, 1997
17.Paliwal S et al. Targeting of C-terminal binding protein (CtBP) by ARF Results in p53-independent apoptosis. Mol Cell Biol, 26, 2360-2372, 2006
18.Ilyas M. Wnt signalling and the mechanistic basis of tumour development. J Pathol, 205, 130-144, 2005
19.Stea B et al. Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’). Cancer Lett, 202, 43-51, 2003
20.Ochs JS. Rationale and clinical basis for combining gefitinib (Iressa, ZD1839) with radiation therapy for solid tumors. Int J Radiat Oncol Biol Phys, 58, 941-949, 2004
21.Janmaat ML et al. Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors. The Oncologist 8, 576-586, 2003
22.Chojnacka M et al. Medulloblastoma in childhood: impact of radiation technique upon the outcome of treatment. Pediatr Blood Cancer, 42, 155-60, 2004
23.Oren M. Decision making by p53: life, death and cancer. Cell Death and Differ, 10, 431-442, 2003
24.Lutolf et al. Notch1 is required for neuronal and glial differentiation in the cerebellum. Development 2002; 129:373
25.Fan X, et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 2004; 64:7787-7793
26.Hallahan AR, et al. The SmoA1 mouse model reveals that Notch signaling is critical for the growth and survival of Sonic Hedgehog-induced medulloblastoma. Cancer Res 2004; 64:7794-7800
27.Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Develop 2003; 13:34
28.Gutzman DH et al. Mouse model of human cancer consortium symposium on nervous system tumors. 2003 Cancer Res 63: 3001 -3004
29.Tong WM et al. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. Am J Pathol. 2003;162(1):343-52.
30.Pazzaglia S et al. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene. 2002;21(49):7580-4.
31.Lee, Y.et al. A molecular fingerprint for medulloblastoma. Cancer Res 2003: 63:5428-37
32.Berman DM et al. . Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-61 (2002)
33.Romer JT et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004; 6:229-40
34.Bjerkvig R, et al. Tumor cell invasion and angiogenesis in the central nervous system. Curr Opin Oncol 1997; 9: 223-229
35.Assimakopoulou M, et al. Microvessel density in brain tumors. Anticancer Res 1997; 17 4747-4753.
36.Ozer E, et al. Prongnostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study. Pathol Resercg Pract 2004; 200: 501-509
37.Huber H, et al. Angiogenic profile of childhood primitive neuroectodermal brain tumours /medulloblastoma. Eur J Cancer 2001; 37: 2064-2072.
38.Masood R, et al. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001; 98:1904-1913
39.Koch A, et al. Somatic mutations of WNT/WINGLESS signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001; 93: 445-449
40.Easwaran V, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003; 63: 3145-3153
41.Dahmen RP, et al. Delations of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001; 61: 7039-7043
42.Easwaran V, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003; 63: 3145-3153
43.Reya T et al.cancer stem cells. Nature 414: 105-111 (2001)
44.Hemmati HD et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 103:15178-15183 (2003)
45.Singh SK. Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828 (2003)
46.Singh SK et al. Identification of human brain tumour initiating cells. Nature 432:396-401 (2004)
47.Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15:61-79 (1994)
48.Simeone A et al. Retinoic acid induces stage-specific antero-posterior transformation of rostral central nervous system. Mech Dev 51:83-98 (1995)
49.Hallahan AR al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9:1033-1038 (2003)
50.Gumireddy K et al. All-trans-retinoic acid-induced apoptosis in human medulloblastoma. Clin Cancer Res 9:4052-4059 (2003)
51.Boon K et al. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res 65:703-7 (2005)
52.Di C et al. Identification of OTX2 as a medulloblastoma oncogene. Cancer Res 65:919-924 (2005)
53.Sun SY and Lotan R. Retinoids and their receptors in cancer development and chemoprevention.Crit Rev Oncol Hematol. 41:41-55 (2002)
54.Tallman MS et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood. 100:4298-302 (2002)
55.Garattini E et al. Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. Curr Pharm Des. 10:433-48 (2004)
56.Cincinelli R.et al. Novel atypical retinoid endowed with proapoptotic and antitumor activity. J. Med. Chem. 46:909-12 (2003)
57.Zuco V. et al. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid. Cell Death Differ. Mar.11:280-9 (2004)

Parole Chiave

MEDULLOBLASTOMA, VIE MOLECOLARI, SONIC HEDGEHOG, WNT, BETA-CATENINA, CELLULE STAMINALI NEOPLASTICHE, MODELLI ANIMALI, TERAPIA